BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24041921)

  • 1. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
    Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
    Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
    Kozela E; Pilc A; Popik P
    Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats.
    Rasmussen K; Martin H; Berger JE; Seager MA
    Neuropharmacology; 2005 Feb; 48(2):173-80. PubMed ID: 15695156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
    Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
    Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test.
    Sevostianova N; Danysz W
    Neuropharmacology; 2006 Sep; 51(3):623-30. PubMed ID: 16793067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
    Lee HG; Park SK; Yoon MH
    Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
    Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Group I metabotropic glutamate receptors antagonists on the expression of NMDA receptor NR1 subunit in morphine tolerant rats.
    Liu JB; Yao YX; Jiang W
    Neurosci Lett; 2009 Mar; 452(3):268-72. PubMed ID: 19348736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
    Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
    Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
    Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.
    Gass JT; Olive MF
    Eur J Pharmacol; 2008 Apr; 584(2-3):253-62. PubMed ID: 18346726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception.
    Hu Y; Dong L; Sun B; Guillon MA; Burbach LR; Nunn PA; Liu X; Vilenski O; Ford AP; Zhong Y; Rong W
    Neurosci Lett; 2009 Jan; 450(1):12-7. PubMed ID: 19027050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q; Sun ML; Chen Y; Li XY; Wang YX
    J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of metabotropic glutamate receptor 5 in spinal cord of morphine tolerant rats].
    Liu JB; Jiang W; Wang AZ
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2221-4. PubMed ID: 20058604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):87-90. PubMed ID: 8584250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.